51 related articles for article (PubMed ID: 33833834)
1. The effectiveness of HPV16 and HPV18 genotyping and cytology with different thresholds for the triage of human papillomavirus-based screening on self-collected samples.
Song F; Du H; Wang C; Huang X; Wu R;
PLoS One; 2020; 15(6):e0234518. PubMed ID: 32525936
[TBL] [Abstract][Full Text] [Related]
2. Human papillomavirus types in cervical high-grade lesions or cancer among Nordic women-Potential for prevention.
Dovey de la Cour C; Guleria S; Nygård M; Trygvadóttir L; Sigurdsson K; Liaw KL; Hortlund M; Lagheden C; Hansen BT; Munk C; Dillner J; Kjaer SK
Cancer Med; 2019 Feb; 8(2):839-849. PubMed ID: 30632704
[TBL] [Abstract][Full Text] [Related]
3. Human papillomavirus genotype contribution to cervical cancer and precancer: Implications for screening and vaccination in Japan.
Onuki M; Matsumoto K; Iwata T; Yamamoto K; Aoki Y; Maenohara S; Tsuda N; Kamiura S; Takehara K; Horie K; Tasaka N; Yahata H; Takei Y; Aoki Y; Kato H; Motohara T; Nakamura K; Ishikawa M; Kato T; Yoshida H; Matsumura N; Nakai H; Shigeta S; Takahashi F; Noda K; Yaegashi N; Yoshikawa H
Cancer Sci; 2020 Jul; 111(7):2546-2557. PubMed ID: 32372453
[TBL] [Abstract][Full Text] [Related]
4. Impact of human papillomavirus types on uterine cervical neoplasia.
Taguchi A; Yoshimoto D; Kusakabe M; Baba S; Kawata A; Miyamoto Y; Mori M; Sone K; Hirota Y; Osuga Y
J Obstet Gynaecol Res; 2024 Jun; ():. PubMed ID: 38852606
[TBL] [Abstract][Full Text] [Related]
5. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer.
Arbyn M; Ronco G; Anttila A; Meijer CJ; Poljak M; Ogilvie G; Koliopoulos G; Naucler P; Sankaranarayanan R; Peto J
Vaccine; 2012 Nov; 30 Suppl 5():F88-99. PubMed ID: 23199969
[TBL] [Abstract][Full Text] [Related]
6. Human Papillomavirus Prevalence and Type Distribution Among 968 Women in South Korea.
So KA; Hong JH; Lee JK
J Cancer Prev; 2016 Jun; 21(2):104-9. PubMed ID: 27390739
[TBL] [Abstract][Full Text] [Related]
7. HPV genotyping for triage of women with abnormal cervical cancer screening results: a multicenter prospective study.
Nakamura Y; Matsumoto K; Satoh T; Nishide K; Nozue A; Shimabukuro K; Endo S; Nagai K; Oki A; Ochi H; Morishita Y; Noguchi M; Yoshikawa H
Int J Clin Oncol; 2015 Oct; 20(5):974-81. PubMed ID: 25652908
[TBL] [Abstract][Full Text] [Related]
8. HPV16/18 genotyping for the triage of HPV positive women in primary cervical cancer screening in Chile.
Lagos M; Van De Wyngard V; Poggi H; Cook P; Viviani P; Barriga MI; Pruyas M; Ferreccio C
Infect Agent Cancer; 2015; 10():43. PubMed ID: 26600869
[TBL] [Abstract][Full Text] [Related]
9. Correlation of the HPV 16 Genotype Persistence in Women Undergoing LEEP for CIN3 with the Risk of CIN2+ Relapses in the First 18 Months of Follow-Up: A Multicenter Retrospective Study.
Bruno MT; Valenti G; Ruggeri Z; Incognito GG; Coretti P; Montana GD; Panella MM; Mereu L
Diagnostics (Basel); 2024 Feb; 14(5):. PubMed ID: 38472983
[TBL] [Abstract][Full Text] [Related]
10. Consistent condom use increases spontaneous regression in high-risk non-HPV16 but not in HPV16 CIN2-3 lesions, a prospective population-based cohort study.
Munk AC; Ovestad IT; Gudlaugsson E; Løvslett K; Fiane B; van Diermen-Hidle B; Kruse AJ; Skaland I; Janssen EA; Baak JP
Infect Agent Cancer; 2012 Nov; 7(1):30. PubMed ID: 23126423
[TBL] [Abstract][Full Text] [Related]
11. The High-Risk Human Papillomavirus Type Influences the Tissue Microenvironment in Cervical Intraepithelial Neoplasia Grade 2.
Saito M; Rajesh A; Innes C; van der Griend R; Fitzgerald P; Simcock B; Sykes P; Hibma M
Viruses; 2023 Sep; 15(9):. PubMed ID: 37766359
[TBL] [Abstract][Full Text] [Related]
12. The changing nature of HPV associated with high grade cervical lesions in vaccinated populations, a retrospective study of over 1700 cases in Scotland.
Cuschieri K; Palmer T; Graham C; Cameron R; Roy K
Br J Cancer; 2023 Oct; 129(7):1134-1141. PubMed ID: 37563221
[TBL] [Abstract][Full Text] [Related]
13. Progression of cervical intraepithelial neoplasia grade 2 lesions among Japanese women harboring different genotype categories of high-risk human papillomaviruses.
Karube A; Saito F; Waga M; Yokoyama S; Kanamori K
J Rural Med; 2021 Apr; 16(2):91-97. PubMed ID: 33833834
[No Abstract] [Full Text] [Related]
14. Clinical Significance of the Interaction between Human Papillomavirus (HPV) Type 16 and Other High-Risk Human Papillomaviruses in Women with Cervical Intraepithelial Neoplasia (CIN) and Invasive Cervical Cancer.
Spinillo A; Dominoni M; Boschi AC; Sosso C; Fiandrino G; Cesari S; Gardella B
J Oncol; 2020; 2020():6508180. PubMed ID: 33178274
[TBL] [Abstract][Full Text] [Related]
15. Cervical Intraepithelial Neoplasia Grade 3 (CIN3) in Women Younger than 30 Years Was Significantly Associated with HPV16/18 Genotypes.
Bruno MT; Panella MM; Valenti G; Ruggeri Z; Sgalambro F; Reina S; Mereu L
Cancers (Basel); 2024 May; 16(11):. PubMed ID: 38893161
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
